San Diego convention Center: June 22 – 25 – 2026
We are preparing to raise funds, with part already secured, to complete our regulatory preclinical studies, with CTA submission targeted for late 2027.
SATT AxLR enters the capital of Aceso Therapeutics and supports the development of ACT-101 for cystic fibrosis
Montpellier, March 2026 — Aceso Therapeutics announces the entry of SATT AxLR into its capital, marking a new milestone in the development of its biotech focused on innovative therapies for cystic fibrosis.
European Young Investigators Meeting (EYIM) – March 2026
European Young Investigators Meeting (EYIM) – 2026
Collaboration between Aceso Therapeutics and the University of Montpellier to develop a new therapy for cystic fibrosis
Montpellier, February 2026 — Aceso Therapeutics and the Université de Montpellier, in collaboration with the PhyMedExp laboratories, announce a research collaboration dedicated to the development of new therapeutic approaches for cystic fibrosis.
ACESO Therapeutics announces progress in advancing its cystic fibrosis therapeutic pipeline
ACESO continues to build a scientific foundation for a new generation of cystic fibrosis therapy focused on patients underserved by current treatment options. ACESO Therapeutics is advancing a therapeutic strategy designed to address meaningful gaps in cystic fibrosis care. While current modulators have changed the treatment landscape for many patients, significant unmet needs remain for […]
Deeptech Connect 2025
AcesoTherapeutics will be attending Deeptech Connect on November 4, 2025 – the flagship event organized by the #SATT network, showcasing the best of French #Deeptech startups. 🎯 A great opportunity to discover an investment opportunity in our novel cystic fibrosis drug program, currently entering the preclinical (IND-enabling) stage. 🔗 for more information : 📍 Deeptech Connect – CENTQUATRE-PARIS ➕ www.deeptechconnect.fr
Innovation Award 2025
🎉 Congratulations to Magali Taulan-Cadars and Prisca Boisguerin for winning the 2025 Innovation « Coup de cœur » Award with their StabCFTR project, aiming to improve care for cystic fibrosis patients. 🏆 The award was presented on July 8, 2025, at the 6th Innovation Afterwork hosted by the University of Montpellier at the beautiful Jardin des Plantes. […]
EUROPEAN CYSTIC FIBROSIS SOCIETY 2025
CFTR stabilizers as therapeutic tools in cystic fibrosis